Chitogen Inc Information

Built upon proprietary technology, Chitogen provides high performance hemostatic products to rapidly stop bleeding. Chitogen has U.S. FDA 510(k) clearances for its range of SoftSeal®-STF Hemostatic Pads. Clinical studies have been very positive, with a high level of provider satisfaction. Chitogen’s range of products include SoftSeal®-STF, which is used in femoral procedures, SoftSeal®-STFR, ideal for radial procedures and D-Seal®, a hemostatic pad designed specifically for the hemodialysis market. Additionally, Chitogen is in early trial development for a patented combination product for the trauma wound care market, including emergency and military applications.

Website	https://www.chitogen.com
Revenue	$4 million
Employees	7 (5 on RocketReach)
Founded	2007
Address	12805 Highway 55, 202, Minneapolis, Minnesota 55441, US
Phone	+1 763-559-5673
Industry	Medical Equipment Manufacturing, Manufacturing General, Hardware, Medical Supplies, Manufacturing, Intrusion Detection, Information Technology, Privacy and Security, Medical Device, Health Care
Keywords	Hemostasis, Bleeding Control, Blood Clotting, Wound Care, Fda Cleared, Soft Tissue Repair, Surgical Sealant, Medical Devices, Advanced Wound Care, Biomaterials, Trauma Care, Biomedical Technology, Surgical Supplies, Medical Supplies, Emergency Medicine
Competitors	AstraZeneca, Smith+Nephew, Integra LifeSciences, MiMedx, Organogenesis, Sientra, Inc., MediWound Ltd., Tissue Regenix Group, Lorem Cytori USA, Inc, Celleration, Inc. +34 more (view full list)
SIC	SIC Code 38 Companies, SIC Code 384 Companies
NAICS	NAICS Code 339 Companies, NAICS Code 33 Companies